Cancer Research U.K. (CRUK) will collaborate with Aleta Biotherapeutics for the early phase clinical development of the ALETA-001, which is Aleta Biotherapeutics’ Cancer therapy candidate.ALETA-001…
Cancer Research U.K. (CRUK) will collaborate with Aleta Biotherapeutics for the early phase clinical development of the ALETA-001, which is Aleta Biotherapeutics’ Cancer therapy candidate.ALETA-001…